Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).
Notes:
Sample sizes (n) refer to the number of respondents for the 15 to 34 year age group. For number of respondents for the whole surveys see epidemiological tables on population surveys in the 2006 statistical bulletin.
Data are from the most recent national surveys available in each country (see Epidemiological Tables on Population Surveys, EMCDDA statistical bulletin).
For young adults, the EMCDDA standard age range is 15 to 34 years (Denmark and UK from 16, Czech Republic, Estonia, Hungary and Germany from 18 years). Variations in age ranges may slightly influence some national differences. In some countries the figures were recalculated at national level, to adapt as far as possible to standard EMCDDA age groups.
Czech Republic: 2004; n=1414
Denmark: 2000; n=4141
Germany: 2003; n=3775
Estonia: 2003; n=646
Greece: 2004; n=2620
Spain: 2003; n=5357
France: 2002; n=724
Ireland: 2002/03; n=
Italy: 2003; n=5231
Latvia: 2003; n=4534 15-64 y.
Lithuania: 2004; n=1814
Hungary: 2003; n=2319
Netherlands: 2001; n=6687
Austria: 2004; n=1754
Poland: 2002; n=3148 16+ y.
Portugal: 2001; n=5472
Slovakia: 2004; n=578
Finland: 2004; n=1031
UK (E&W): 2004/05; n=9913
Bulgaria: 2005; n=433
Norway: 2004; n=1238
See also 'General notes for interpreting data' on the Explanatory notes and help page.
Sources:
Reitox national reports (2005), taken from surveys reports or scientific articles.